Eian Kantor

Why racial diversity in clinical trials is so important

Many factors can influence how individuals react to certain drugs, medical devices, and treatment plans. Age, biological sex, disabilities, chronic comorbidities, geographical location, gender identity, race, and ethnic background are all important components of medical decision making.

Continue reading

How lab partnerships are key for virtual trials

Amidst the COVID-19 pandemic, finding ways to be innovative with clinical trial patient recruitment has been the name of the game. One trend we’re seeing is the rise of virtual trials, which has made it easier and safer for more people to participate in research. But even if a trial is fully virtual, sample collection may still need to happen to determine eligibility, so one critically important ...

Continue reading

Interview with Sara Gorman, lupus community advocate

In our work, we’re privileged to meet many patient advocates who are, in their own ways, making life with illness easier for others. Sara Gorman is the owner of a company called Sara Gorman's Pillbags, which creates stylish weekly pill organizers. She has a lupus blog and is the author of Despite Lupus. And, she’s a powerful advocate for the lupus community. We talked to her about her personal ...

Continue reading

How long do clinical trial phases take?

Before a potential new therapy can reach patients, it goes through several clinical trial phases that test an intervention for both safety and effectiveness. Looking at the big picture, it takes approximately ten years for a new treatment to complete the journey from initial discovery to the marketplace. Clinical trials alone take six to seven years on average to complete.

Continue reading

“Participation for progress,” a new whitepaper in partnership with Antidote, BrightFocus Foundation, and PatientPoint

Antidote partnered with the BrightFocus Foundation and PatientPoint to survey more than 650 patients living with cognitive disorders and their care partners. We sought to understand patterns of diagnosis as well as reasons patients do or do not take part in clinical research — with the ultimate goal of recognizing opportunities to improve patient engagement around research participation.

Continue reading

How to run the perfect clinical trial recruitment campaign

Many factors play into running a successful clinical trial. Patient recruitment has an infamous reputation for taking a long time and slowing down the research process. However, with the right patient recruitment strategies, enrolling volunteers doesn’t have to halt your trial’s progress. 

Continue reading

COPD resources: Where to find the information and support you need

More than 16 million Americans have chronic obstructive pulmonary disease, commonly referred to as COPD, and millions more have it but don’t know it. COPD is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Emphysema and chronic bronchitis are the two most prevalent conditions that contribute to the development of COPD. Signs of COPD include ongoing cough, ...

Continue reading

Advertising clinical trials: Do's and Don'ts

A major challenge in clinical trial advertising is being creative within the scope of institutional review board (IRB) and FDA guidelines, as well as distribution channel rules. While it can take more time and research to craft copy within such narrow parameters, it is definitely still possible to engage patients without breaking the rules.

Continue reading

Interview with the Hepatitis B Foundation

The Hepatitis B Foundation is a national nonprofit organization dedicated to finding a cure and improving the quality of life for those affected by hepatitis B worldwide. We’re proud to partner with them to help people living with hepatitis B find and take part in clinical trials.

Continue reading

Virtual or traditional trials: Considerations for making trial design decisions

When it comes to running a clinical trial, researchers have been getting creative, trading traditional processes for virtual opportunities. This has become especially apparent in light of the COVID-19 pandemic. 

Continue reading

Get our latest posts in your inbox.